NEW YORK (GenomeWeb) – Sigma-Aldrich today announced a collaboration to supply its CRISPR technology to the Czech Center for Phenogenomics (CCP).
Under the collaboration, Sigma-Aldrich will provide the Transgenic Module at the CCP's Institute of Molecular Genetics with Sigma CRISPR technology, including reagents, experimental design consultation, and dedicated gene editing bioinformaticians.
"The Sigma-Aldrich CRISPR Core Lab Collaboration helps accelerate the pace of translational research by removing design and production hurdles with CRISPR or zinc finger nucleases, allowing scientists at the transgenic facility to focus on developing animal models that reflect the human condition," Sigma-Aldrich Director of Strategic Marketing and Collaborations Sean Muthian said in a statement.
The deal will help the CCP to ramp up its genetic engineering services. "Requests for these technologies have undergone substantial growth over the past year, reaching almost 100 projects at the end of 2014," CCP Director Radislav Sedlacek said. "Our collaboration with Sigma-Aldrich will allow us to further improve our service efficiency and keep pace with our growing order book."
In September, Sigma-Aldrich signed a CRISPR core lab collaboration deal with the University of Michigan.
Financial details of the agreement were not disclosed.